17 June 2024
17 June 2024
The approval is based on a subgroup analysis from the DUO-E Phase III trial, which focused on MMR status.
Keeping high-qualified, experienced clinical trial staff on board plays a crucial role in bringing new drugs to market. Dana Durkan of KPS Life discusses how to avoid fraudulent staff, navigate work from home dynamics, and keep hold of your most valued employees.
The FDA granted approval ased on outcomes from the Phase I/II TRIDENT-1 study.
The approval is based on the findings from the Phase III E1910 clinical trial.
Based on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines of therapy for diffuse large B-cell lymphoma (DLBCL).
The JN.1 vaccine demonstrated broad cross-neutralising antibodies effective against various variant strains.
With the closure of the Series B2 round, Enveda's total capital raised stands at $230m.
Demand still outpaces supply for the GLP-1RA drugs that have transformed diabetes care.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
